TrialBritish journal of cancer2003

A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473).

P Beale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.